Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid

BioTechGrid

  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
Posted inGenetics

ParcelBio Unveils Programmable mRNA Platform Backed by $13M Financing

May 8, 2026
Continue Reading
parcelbio-unveils-programmable-mrna-platform-backed-by-$13m-financing
Posted inGenetics

Gene Therapy Briefs: Regeneron Wins FDA Approval for First Neurosensory Gene Therapy

May 8, 2026
Continue Reading
gene-therapy-briefs:-regeneron-wins-fda-approval-for-first-neurosensory-gene-therapy
Posted inGenetics

ASGCT Honors Mohamed Abou‑el‑Enein as Outstanding New Investigator

May 8, 2026
Continue Reading
asgct-honors-mohamed-abou‑el‑enein-as-outstanding-new-investigator
Posted inBiotechnology

Advancing Drug Development: Chinese Medical Journal Reviews Organoid Models in New Drug Regulation

May 8, 2026
Continue Reading
advancing-drug-development:-chinese-medical-journal-reviews-organoid-models-in-new-drug-regulation
Posted inBiotechnology

From Immunosuppression to Immune Harmony: Advancing Regulatory T Cell Therapy in Organ Transplantation

May 8, 2026
Continue Reading
from-immunosuppression-to-immune-harmony:-advancing-regulatory-t-cell-therapy-in-organ-transplantation
Posted inBiotechnology

Single Workout May Rapidly Reduce Smoking Cravings, Study Finds

May 8, 2026
Continue Reading
single-workout-may-rapidly-reduce-smoking-cravings,-study-finds
Most Popular Post
exploring-the-future-of-healthcare with-panos-karelis
Posted inArtificial intelligence

Exploring the Future of Healthcare with Panos Karelis

exploring-the-future-of-healthcare with-gordon-wishart,-check4cancer
Posted inArtificial intelligence

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

exploring-the-future-of-healthcare with-noam-shomron,-tel-aviv-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

exploring-the-future-of-healthcare with-raul-villamarin-rodriguez,-woxsen-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

flu-vaccine-response-boosted-by-coupling-antigens-from-multiple-subtypes
Posted inGenetics

Flu Vaccine Response Boosted by Coupling Antigens from Multiple Subtypes

December 19, 2024
The seasonal influenza vaccine contains strains of viruses from distinct virus subtypes, but most people who are vaccinated will mount…
Read More
pyxis-oncology-shelves-antibody-to-focus-on-sole-clinical-asset,-an-adc-licensed-from-pfizer
Posted inBiotechnology

Pyxis Oncology shelves antibody to focus on sole clinical asset, an ADC licensed from Pfizer

December 19, 2024
Pyxis Oncology is shelving a clinical-stage monoclonal antibody to focus on its lead antibody-drug conjugate (ADC) after sharing preliminary results…
Read More
oncology-biotech-epitopea-licenses-genevant-nucleic-acid-delivery-tech-for-up-to-$123m
Posted inBiotechnology

Oncology biotech Epitopea licenses Genevant nucleic acid delivery tech for up to $123M

December 19, 2024
To develop RNA medicines targeting a proprietary bundle of tumor antigens, Epitopea is tapping nucleic acid delivery specialist Genevant Sciences…
Read More
chutes-&-ladders—fda’s-principal-deputy-to-depart-agency
Posted inBiotechnology

Chutes & Ladders—FDA’s principal deputy to depart agency

December 19, 2024
Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please…
Read More
omeros-antibody-improves-overall-survival-by-68%-in-rare-condition,-new-analysis-finds
Posted inBiotechnology

Omeros antibody improves overall survival by 68% in rare condition, new analysis finds

December 19, 2024
Omeros is putting up its monoclonal antibody up for FDA approval—again. This time, the resubmission will be based on a…
Read More
merck’s-hiv-combo-treatment-meets-the-bar-for-viral-suppression-in-pair-of-phase-3-studies
Posted inBiotechnology

Merck’s HIV combo treatment meets the bar for viral suppression in pair of phase 3 studies

December 19, 2024
After hitting the mark in a phase 2 of its investigational islatravir paired with Gilead’s lenacapivir, Merck & Co.'s islatravir…
Read More
vc-firm-pens-$608m-biobucks-deal-to-redirect-ngm’s-mash-drug-to-rare-disease
Posted inBiotechnology

VC firm pens $608M biobucks deal to redirect NGM’s MASH drug to rare disease

December 19, 2024
KdT Ventures has signed off on a $608 million biobucks deal for NGM Biopharmaceuticals’ phase 2-ready metabolic-dysfunction associated steatohepatitis (MASH)…
Read More
scinai-immunotherapeutics-establishes-us.-cdmo-subsidiary
Posted inGenetics

Scinai Immunotherapeutics Establishes U.S. CDMO Subsidiary

December 19, 2024
Scinai Immunotherapeutics, which focuses on developing inflammation and immunology biological products and providing CDMO services through its Scinai Bioservices business…
Read More
regeneron-anticoagulant-bests-enoxaparin,-matches-eliquis-in-phase-2-trial
Posted inBiotechnology

Regeneron anticoagulant bests enoxaparin, matches Eliquis in phase 2 trial

December 19, 2024
A pair of Regeneron’s monoclonal antibodies have held their own against a commonly used anticoagulant in a phase 2 trial,…
Read More
vertex’s-pain-trial-hits-endpoint-but-sinks-stock-as-placebo-comparison-spooks-investors
Posted inBiotechnology

Vertex’s pain trial hits endpoint but sinks stock as placebo comparison spooks investors

December 19, 2024
Vertex has reported a phase 2 win that still dented confidence in its pain prospect suzetrigine. The trial linked the near-approval…
Read More

Posts pagination

Previous page 1 … 1,790 1,791 1,792 1,793 1,794 … 1,804 Next page
You May Have Missed
roche-shells-out-up-to-$1b-for-pathai-in-move-to-boost-artificial-intelligence-powered-diagnostics
Posted inMedical Technology

Roche shells out up to $1B for PathAI in move to boost artificial intelligence-powered diagnostics

insulet-boosts-guidance-in-q1-update-as-it-grapples-with-recall-saga
Posted inMedical Technology

Insulet boosts guidance in Q1 update as it grapples with recall saga

j&j’s-ottava-surgical-robot-meets-primary-endpoints-in-gastric-bypass-study
Posted inMedical Technology

J&J’s Ottava surgical robot meets primary endpoints in gastric bypass study

olympus,-endorobotics-in-distribution-pact-for-robot-assisted-endoscopic-tech
Posted inMedical Technology

Olympus, EndoRobotics in distribution pact for robot-assisted endoscopic tech

Privacy Policy    Terms

Scroll to Top